Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by Str8Shuteron Mar 22, 2021 12:43pm
207 Views
Post# 32850800

Possible Buying Opportunity on Friday

Possible Buying Opportunity on FridayI have noticed a few folks on this forum referring to this Friday as some kind of deadline for a NR on the launch of Aristotle.  If the company's word is to be trusted, then the deadline should actually be next Wednesday, Mar. 31

If enough traders are somehow convinced that Q1 ends this Friday, Mar. 26, then there could be an opportunity to accumulate some cheap shares because that misunderstanding (or perhaps strategic misdirection?) may result in some Friday afternoon dumping in the absense of any news.

So, it will be good to keep some "dry powder" handy.  Planning to have a so-called "stink bid" in place, just in case that does happen.

GLTA!
<< Previous
Bullboard Posts
Next >>